Home Your basket
• Surgical anatomy of the f...
   Price 10.50 €
• Karapandzic flap for reco...
   Price 10.50 €
• Different clinical approa...
   Price 5.50 €
• Acoustic analysis of the ...
   Price 10.50 €
• Recovery of saccular func...
   Price 8.50 €
• Hearing aid : practical a...
   Price 8.50 €
• What we don’t know about ...
   Price 12.50 €
• Comparison between extern...
   Price 10.50 €
• Vestibular neuritis: aeti...
   Price 8.50 €
• Solitary fibrous tumour o...
   Price 8.50 €
• Feasibility study of sept...
   Price 10.50 €
• Parathyroïd adenoma induc...
   Price 8.50 €
• A post-styloid mass revea...
   Price 12.50 €
• Positioning in the oropha...
   Price 8.50 €
• New trends in rhinoplasty...
   Price 10.50 €
• Paediatric endoscopic sin...
   Price 10.50 €
• A rare case of sarcoidosi...
   Price 5.50 €
• Congenital cyst and fistu...
   Price 10.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Seven cases of inverted n...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Sinonasal malignant schwa...
   Price 5.50 €
• Prosthetics gains and sat...
   Price 12.50 €
• Dehiscence of the anterio...
   Price 8.50 €
• Explorations of the velum...
   Price 14.00 €
• Inverted naso-sinus papil...
   Price 10.50 €
• Arachnoid granulations of...
   Price 10.50 €
• The role of larynx kinest...
   Price 10.50 €
• Mandibular reconstruction...
   Price 8.50 €
• Hearing aids rehabilitati...
   Price 12.50 €
• Trigeminal neuralgia: An ...
   Price 10.50 €

Total Order 296.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2008 o

CERVICO-FACIAL CARCINOLOGY

Sarcomatoid carcinomas of the upper airways


Authors : Oueslati Z, Ben Miled M, Hammoud M, Touati S, Lachkham A, Gamoudi A, Mokni N, El Benna F, Boussen H, El May A, Ladgham A. (Tunis)

Ref. : Rev Laryngol Otol Rhinol. 2008;129,3:191-195.

Article published in french
Downloadable PDF document french



Summary : Introduction: The sarcomatoid carcinoma of the superior aerodigestive tracts is a rare malignant tumour, which presents diagnostic and therapeutic challenges. Material and method: We report 11 cases of spindle cell carcinomas of the upper airways. Results: Sex-ratio was 10:1 and the mean age was 57.3 years (30 - 75 years). Nine patients were smokers and 4 presented with a history of radiation exposure. Tumoral locations were as follows: larynx: 6, hypopharynx: 1, oropharynx: 1, nasopharynx: 1, oral cavity: 2. Histological diagnosis in 3 cases required the use of immunohistochemical studies. Four patients were first seen at an advanced stage. This left 9 patients and among them 7 received a curative treatment: 5 by surgery alone, 1 by surgery and radiotherapy, 1 by radiotherapy, 1 by chemo-radiotherapy for the nasopharyngeal lesion and 1 by chemotherapy alone. Two patients died from their disease before treatment. With an average delay of 15.4 months, the rates of global survival and disease-free were 5/9 and 4/9 respectively. Conclusion: The sarcomatoid carcinoma of the upper airways is rare, but not unusual. Its diagnosis benefits from progresses in immunohistochemistry, but also from advances in the field of molecular biology. Its treatment and natural evolution remain controversial.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE